166 related articles for article (PubMed ID: 15225763)
1. Insights into Vitamin D metabolism using cyp24 over-expression and knockout systems in conjunction with liquid chromatography/mass spectrometry (LC/MS).
Masuda S; Kaufmann M; Byford V; Gao M; St-Arnaud R; Arabian A; Makin HL; Knutson JC; Strugnell S; Jones G
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):149-53. PubMed ID: 15225763
[TBL] [Abstract][Full Text] [Related]
2. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
3. Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24.
Sakaki T; Sawada N; Komai K; Shiozawa S; Yamada S; Yamamoto K; Ohyama Y; Inouye K
Eur J Biochem; 2000 Oct; 267(20):6158-65. PubMed ID: 11012668
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of 20-epimer of 1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
Kusudo T; Sakaki T; Abe D; Fujishima T; Kittaka A; Takayama H; Ohta M; Inouye K
Biochem Biophys Res Commun; 2003 Oct; 309(4):885-92. PubMed ID: 13679056
[TBL] [Abstract][Full Text] [Related]
5. Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism.
Schuster I; Egger H; Reddy GS; Vorisek G
Recent Results Cancer Res; 2003; 164():169-88. PubMed ID: 12899522
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of 26,26,26,27,27,27-F6-1alpha,25-dihydroxyvitamin D3 by CYP24: species-based difference between humans and rats.
Sakaki T; Sawada N; Abe D; Komai K; Shiozawa S; Nonaka Y; Nakagawa K; Okano T; Ohta M; Inouye K
Biochem Pharmacol; 2003 Jun; 65(12):1957-65. PubMed ID: 12787875
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms for the reduction of 24,25-dihydroxyvitamin D3 levels and bone mass in 24-hydroxylase transgenic rats.
Hosogane N; Shinki T; Kasuga H; Taketomi S; Toyama Y; Suda T
FASEB J; 2003 Apr; 17(6):737-9. PubMed ID: 12594170
[TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-dihydroxyvitamin D3-24-hydroxylase (CYP24) hydroxylates the carbon at the end of the side chain (C-26) of the C-24-fluorinated analog of 1alpha,25-dihydroxyvitamin D3.
Miyamoto Y; Shinki T; Yamamoto K; Ohyama Y; Iwasaki H; Hosotani R; Kasama T; Takayama H; Yamada S; Suda T
J Biol Chem; 1997 May; 272(22):14115-9. PubMed ID: 9162038
[TBL] [Abstract][Full Text] [Related]
9. Characterization of vitamin D-mediated induction of the CYP 24 transcription.
Tashiro K; Abe T; Oue N; Yasui W; Ryoji M
Mol Cell Endocrinol; 2004 Oct; 226(1-2):27-32. PubMed ID: 15489002
[TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
11. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas.
Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M
Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of vitamin D hydroxylases in human keratinocytes.
Schuster I; Egger H; Bikle D; Herzig G; Reddy GS; Stuetz A; Stuetz P; Vorisek G
Steroids; 2001; 66(3-5):409-22. PubMed ID: 11179750
[TBL] [Abstract][Full Text] [Related]
13. Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs.
Jones G; Byford V; West S; Masuda S; Ibrahim G; Kaufmann M; Knutson JC; Strugnell S; Mehta R
Anticancer Res; 2006; 26(4A):2589-95. PubMed ID: 16886668
[TBL] [Abstract][Full Text] [Related]
14. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
[TBL] [Abstract][Full Text] [Related]
15. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
[TBL] [Abstract][Full Text] [Related]
16. A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assay.
Beumer JH; Parise RA; Kanterewicz B; Petkovich M; D'Argenio DZ; Hershberger PA
Steroids; 2012 Apr; 77(5):477-83. PubMed ID: 22285938
[TBL] [Abstract][Full Text] [Related]
17. Rat cytochrome P450C24 (CYP24) does not metabolize 1,25-dihydroxyvitamin D2 to calcitroic acid.
Horst RL; Omdahl JA; Reddy S
J Cell Biochem; 2003 Feb; 88(2):282-5. PubMed ID: 12520527
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
Miyahara T; Gomyo S; Ueda Y; Ohyama Y; Sigeno C; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Yamamoto M; Sakuma T; Nemoto N
Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic studies on the key enzymes of vitamin D metabolism; 1 alpha-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24).
Inouye K; Sakaki T
Biotechnol Annu Rev; 2001; 7():179-94. PubMed ID: 11686044
[TBL] [Abstract][Full Text] [Related]
20. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.
Swami S; Krishnan AV; Peehl DM; Feldman D
Mol Cell Endocrinol; 2005 Sep; 241(1-2):49-61. PubMed ID: 15955619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
